Insights

Intellectual Property Intellectual Property

Type (0)

Results

All Insights

Osler Update December 13, 2021

Time to talk about ownership of AI-generated intellectual property assets

Systems for protecting intellectual property (IP) have been in place since the Middle Ages, encouraging skilled, innovative technicians by granting...

Read more
Time to talk about ownership of AI-generated intellectual property assets
Osler Update September 24, 2021

The impact of CAR T cell patenting on access to therapy in Canada

A recent U.S. court decision provided narrow patent scope for a basic CAR T therapy patent.

Read more
Osler Update June 21, 2021

Canadian Animal Health Market Update: Companion animals are getting a lot of attention during COVID-19

Work from home has led to an explosion in pet adoption during the pandemic. This is good news for those involved in Canadian animal health.

Read more
Osler Update April 27, 2021

Federal Court of Appeal provides course correction on the interpretation of pharmaceutical certificates of supplementary protection

The Federal Court of Appeal’s latest decision affirms that the Minister of Health is afforded deference in setting CSP policy, provided the...

Read more
Webinar April 22, 2021

Financing Intellectual Property in Early and Growth Stage Fintech Companies

Financing Intellectual Property in Early and Growth Stage Fintech Companies

Read more
Osler Update March 23, 2021

Technology provider not liable for patent infringement without evidence of inducement or agreement to infringe a Canadian patent

This Update discusses the Federal Court of Canada’s decision and its implications in dTechs epm Ltd v British Columbia Hydro and Power Authority...

Read more
Osler Update March 15, 2021

Making sense of the battle for the CRISPR-Cas9 patent rights

There has been an ongoing legal battle for years over the intellectual property of the CRISPR-Cas9 technology. This Update makes sense of the battle...

Read more
Osler Update February 24, 2021

Canadian courts are interpreting supplementary pharmaceutical patent protection more broadly than their EU counterparts

In the first two Canadian Federal Court decisions to interpret the scope of CSPs, the Court ruled in favour of broad CSP protection where similar...

Read more
Osler Update February 18, 2021

Ontario Superior Court denies certification of Cambridge Analytica class action

On February 16, 2021, the Ontario Superior Court of Justice dismissed a motion for class certification in Simpson v. Facebook, Inc., a putative...

Read more
Osler Update January 26, 2021

Choueifaty patent application found to possess patentable subject-matter

The Commissioner of Patents' recent finding provides insight on the application of CIPO’s practice guidance, which is intended to comply with the...

Read more